Christine Emmanuel-Donnelly Acquires 26,478 Shares of Medical Developments International Limited (ASX:MVP) Stock

Medical Developments International Limited (ASX:MVP) insider Christine Emmanuel-Donnelly bought 26,478 shares of the firm’s stock in a transaction on Wednesday, August 28th. The stock was acquired at an average cost of A$0.38 ($0.26) per share, with a total value of A$10,061.64 ($6,844.65).

Medical Developments International Price Performance

The company has a current ratio of 2.74, a quick ratio of 2.54 and a debt-to-equity ratio of 5.00.

Medical Developments International Company Profile

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices.